Nanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Department of Electronics and Biomedical Engineering, University of Barcelona, Barcelona, Spain.
Adv Exp Med Biol. 2022;1379:389-412. doi: 10.1007/978-3-031-04039-9_16.
Nowadays, liquid biopsy represents one of the most promising techniques for early diagnosis, monitoring, and therapy screening of cancer. This novel methodology includes, among other techniques, the isolation, capture, and analysis of circulating tumor cells (CTCs). Nonetheless, the identification of CTC from whole blood is challenging due to their extremely low concentration (1-100 per ml of whole blood), and traditional methods result insufficient in terms of purity, recovery, throughput and/or viability of the processed sample. In this context, the development of microfluidic devices for detecting and isolating CTCs offers a wide range of new opportunities due to their excellent properties for cell manipulation and the advantages to integrate and bring different laboratory processes into the microscale improving the sensitivity, portability, reducing cost and time. This chapter explores current and recent microfluidic approaches that have been developed for the analysis and detection of CTCs, which involve cell capture methods based on affinity binding and label-free methods and detection based on electrical, chemical, and optical sensors. All the exposed technologies seek to overcome the limitations of commercial systems for the analysis and isolation of CTCs, as well as to provide extended analysis that will allow the development of novel and more efficient diagnostic tools.
如今,液体活检代表了癌症早期诊断、监测和治疗筛选最有前途的技术之一。这种新方法包括,除其他技术外,循环肿瘤细胞(CTC)的分离、捕获和分析。然而,由于其极低的浓度(每毫升全血中为 1-100 个),从全血中鉴定 CTC 具有挑战性,传统方法在纯度、回收率、通量和/或处理样本的活力方面都不够充分。在这种情况下,由于其出色的细胞操作性能以及将不同的实验室流程集成到微尺度以提高灵敏度、便携性、降低成本和时间的优势,用于检测和分离 CTC 的微流控设备的发展为其提供了广泛的新机会。本章探讨了目前和最近开发的用于分析和检测 CTC 的微流控方法,其中涉及基于亲和结合和无标记方法的细胞捕获方法,以及基于电、化学和光学传感器的检测方法。所有暴露的技术都旨在克服商业 CTC 分析和分离系统的局限性,并提供扩展分析,从而开发出新型且更有效的诊断工具。